EpicentRx Inc
La Jolla
About EpicentRx Inc
With a prolific platform of small molecule therapies, innate immune checkpoint inhibitors, cell based therapies, vaccines and oncolytic viruses, the central focus of EpicentRx Inc., a privately owned physician-led phase 3 clinical-stage immuno-oncology company located in San Diego, California, is on anticancer immunization and chemo/radioprotection of normal tissues. As a company of actively practicing oncologists/internists they at EpicentRx take cancer very very personally (in a literal and figurative sense) with the plight of the patient serving first and foremost as the motivation to customize or personalize their platform of immunotherapies both to individuals that are otherwise out of options and to groups of individuals with common and in many cases currently undruggable mutations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.5M
- Funding stage: Late Stage Venture
- Last round: Grant (Jul 2022)
- Website: epicentrx.com
- Phone: (858) 947-6635
Industries & Categories
Biotechnology, Oncology
Social Profiles
Canonical: https://fsome.com/organization/epicentrx-inc-150165 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.